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Ivana Škrlec, Svjetlana Marić and Aleksandar Včev
Abstract
Human physiological activity and condition during illness are under the control 
of the circadian rhythm. Circadian rhythms handle a wide diversity of physiological 
and metabolic functions, and the interruption of these rhythms has been linked to 
obesity, sleep disorders, metabolic and psychological disorders, and cardiovascular 
events such as myocardial infarction (MI), stroke, and vascular death. Disruption 
of circadian rhythms increases the risk of developing myocardial infarction, 
indicating that circadian genes might play an essential role in determining disease 
susceptibility. It is well known that many cardiovascular processes show daily varia-
tions depending on the circadian rhythm (blood pressure, heart rate), and the gene 
expression of the cardiomyocyte circadian clock influences myocardial contractile 
function, metabolism, and other gene expressions. We present a review of the 
latest knowledge on the impact of circadian rhythm and circadian rhythm genes on 
myocardial infarction. Today, in a time of personalized medicine, it is essential to 
know each person’s circadian rhythm for its treatment and possible inclusion in the 
diagnostic procedures.
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1. Introduction
Everyday life is organized according to three different clocks: the solar clock 
which gives us light and temperature during the day, the social clock which deter-
mines the working day, and the biological clock which we notice during shift work 
or when we adjust to a reduced amount of daylight. In real life, the circadian clock is 
synchronized within 24 hours of the solar clock [1, 2].
It is known that almost all cardiovascular events occur in a circadian manner 
with a higher frequency in the morning after waking [3]. In the peripheral clocks of 
the cardiovascular tissues or cells, there is daily expression of the clock-controlled 
genes (CCG) synchronized and regulated by central clock [4, 5]. Disturbances of 
circadian rhythm can lead to cardiovascular disease.
Today we are facing a global epidemic of cardiovascular disease. In 2015 car-
diovascular disease was the cause of 17.7 million deaths worldwide or 31% of total 
mortality. Of these 7.4 million deaths were caused by ischemic heart disease and 
6.7 million by cerebrovascular diseases, according to World Health Organization 
(WHO) [6].
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2. Circadian rhythm
Circadian rhythm is controlled by a molecular clock located in almost every cell. 
A hierarchical system organizes molecular clocks—the master clock is located in 
the suprachiasmatic nucleus (SCN) in the hypothalamus [2, 7], while the peripheral 
clocks are located in each organ or cell. The central clock regulates physiological 
functions via the autonomic nervous system, humoral mediators, and other still 
unknown factors [7, 8]. In the maintenance and generation of circadian or biologi-
cal rhythm in humans, a whole series of anatomical (suprachiasmatic nucleus), 
neurological (retinohypothalamic paths) and neuroendocrine (melatonin) systems 
are involved, indicating that the biology of the circadian rhythm of humans is 
similar to that of animals [9].
The master clock in the SCN consists of about 100,000 neurons in humans. It 
is the only molecular clock that receives light as an input signal from the retina. 
Internal clocks are synchronized with light depending on the time of day. SCN 
receives a direct light signal from the retina via the optic nerve from the photore-
ceptor called the intrinsically photoreceptive retinal ganglion cell (ipRGC), which 
expresses the circadian photopigment, melanopsin [10]. The signal is further 
transmitted to peripheral clocks via the endocrine system [11, 12]. The central clock 
synchronizes each of the peripheral clocks in the body, and the primary circadian 
hormone is melatonin [13]. The pineal gland secretes melatonin during the night. 
Melatonin plays an essential role in maintaining the circadian rhythm depending 
on the period of light or darkness. The main difference between the master and 
peripheral clocks is in their degree of intercellular interaction. Peripheral clocks 
are under the influence of the master clock from the SCN via hormones, chemical 
signals and other metabolites (such as food), as well as by changes in the body, such 
as body temperature [11, 12].
On the other hand, due to the high degree of neuron connection the master 
clock in the SCN is not under the influence of internal signals but only under 
the influence of light [14]. Peripheral tissues integrate central clock signals with 
environmental factors (including sleepiness, physical activity, and feeding) and 
their autonomic rhythms which regulate the metabolism in a circadian manner 
[10]. The rhythm of the peripheral clocks in humans is measured by direct mea-
surement of physiological changes, or by determining the expression of the clock 
genes. Central and peripheral clocks together control the daily circadian rhythm of 
the metabolism [15].
Feeding time is one of the key triggers or external factors that sets the phases 
of the peripheral clocks [15]. Complex feedback loops connect the circadian clock 
with metabolic pathways and integrate these systems independently of light [10]. 
It is believed that the central clock regulates the metabolism by hormones (primar-
ily cortisol and melatonin) and synaptic signaling (via the autonomic nervous 
system) [10]. Feeding is a circadian event that serves not only as the output of the 
central clock, but also as an input signal for peripheral clocks because peripheral 
tissues communicate with the brain through ghrelin, leptin, glucose, and insulin. 
Circadian feeding contributes to the interworking of the clock and metabolism, 
which is crucial for metabolic homeostasis [16]. The central clock rhythm is 
primarily related to light, whereas peripheral tissue rhythms derive from the input 
of signals from the central clock, external factors (light, physical activity, feeding, 
and sleepiness) and the availability of numerous metabolites [15]. All these signals 
affect the molecular clock, creating a complex correlation between the circadian 
clock and physiological processes [10]. SCN coordinates all cellular circadian clocks 
in the organs and tissues through its rhythmic outcomes, to adapt physiology to 
Earth’s rotation [17].
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The two clock systems become desynchronized when their drivers or stimuli do 
not coincide because different stimuli affect the phases of the central and periph-
eral clocks. This mismatch disrupts the metabolism because the two clock systems 
coordinate interlinked metabolic pathways. Circadian rhythm mismatch increases 
the risk of developing metabolic diseases [15].
The central clock is primarily triggered by light, and its rhythm is often mea-
sured by determining the concentrations of melatonin, cortisol or body tempera-
ture [15]. The expression of the clock genes is disrupted in pathological conditions. 
Such a change may result in different tissue response to external signals and acceler-
ate tissue damage. The loss of synchronization can lead to various diseases, includ-
ing an increased incidence of cardiovascular disease [18].
3. Molecular basis of circadian rhythm
The central clock genes are expressed in a circadian manner in the SCN, and 
light is one of the main initiators (so-called zeitgeber) and can reset the phase of 
the rhythm. The first circadian rhythm gene discovered was the Per gene in the 
fruit fly in 1971 [19, 20], while the first circadian rhythm gene discovered in the 
vertebrae was the CLOCK gene [21]. There are about 10 circadian rhythm genes 
known to regulate cyclic expression of mRNA and protein, via transcription 
and translation feedback loops [22]. In the SCN there are four essential proteins: 
ARNTL (Aryl Hydrocarbon Receptor Nuclear Translocator-Like) and CLOCK 
(Circadian Locomotor Output Cycles Caps) are activators, while PER (Period) and 
CRY (Cryptochrome) are transcription inhibitors. The feedback of the circadian 
rhythm gene maintains circadian oscillations in one cell at the transcriptional and 
posttranscriptional levels, and the transition from light to dark triggers these oscil-
lations. The whole process of activation and repression of gene expression within 
the loop lasts for about 24 hours. These transcriptional factors trigger numerous 
physiological changes by acting on the expression of the same genes, and other 
clock-controlled genes [23, 24].
ARNTL and CLOCK heterodimers bind to regulatory elements of the promoters 
and enhancers (E-box) of the PER and CRY genes and stimulate their expression 
and the expression of other clock-controlled genes. Overnight the amount of 
PER and CRY proteins gradually increases, and heterodimers are created in the 
cytoplasm. The phosphorylated PER-CRY heterodimers are translocated into the 
nucleus where they inhibit the ARNTL-CLOCK protein complex. Therefore, during 
the day, transcription of PER and CRY genes is reduced, while the levels of PER 
and CRY protein decrease due to their degradation by ubiquitin. The PER-CRY 
heterodimers directly bind to the ARNTL-CLOCK complex, and as PER2 contains 
histone deacetylase, the chromatin structure changes, resulting in transcription 
termination. Also, the PER-CRY heterodimer is in interaction with RNA-binding 
proteins and helicase that are important in stopping transcription independently of 
the interaction with the ARNTL-CLOCK complex. Additionally, PER-CRY het-
erodimers regulate the transcription of various nucleic hormone receptors [25–28].
During the day a new cycle begins by the termination of the ARNTL-CLOCK 
heterodimer inhibition. Casein kinase 1 (CK1) controls the amount of phosphoryla-
tion or degradation of PER-CRY heterodimers and thereby determines the amount 
of PER-CRY heterodimer entering the nucleus and inhibiting the ARNTL-CLOCK 
complex. CK1 phosphorylates the proteins and thus regulates their activity [29].
The additional negative loop is REV-ERBα that binds to the REV-ERB/ROR 
response element (RRE) of the ARNTL and CLOCK genes, and prevents their 
transcription. Also, RORα (Retinoic Acid Receptor-related Orphan Receptor) binds 
Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease
4
to the same regulatory elements of the ARNTL gene as well as REV-ERBα. With 
REV-ERBα degradation overnight, RORα promotes transcription of the ARNTL 
gene [30]. The second regulatory loop consists of ARNTL-CLOCK heterodimers 
which promote the transcription of the nucleic receptors REV-ERBα and RORα [31] 
(Figure 1).
Circadian clock genes have an essential role in many physiological processes. 
Thus, animal models demonstrate that the ARNTL gene plays an essential role in 
lipid metabolism because it induces the expression of genes involved in lipogenesis 
in adipose tissue in a circadian manner [32]. Pancreatic beta cells have a circadian 
clock dependent on ARNTL and CLOCK protein oscillations, which regulate insulin 
secretion depending on the stage of alertness. Abnormalities of the pancreas clock 
may trigger the onset of diabetes [33]. It was found that CLOCK polymorphisms 
are associated with body weight, the risk for metabolic syndrome and insomnia in 
humans [9, 32], and polymorphisms of the PER2 and PER3 genes are associated 
with sleep disorders [34, 35]. Some variants of CRY1 and CRY2 genes are associated 
with metabolic syndrome, particularly hypertension and increased triglyceride 
levels in the blood [36]. Many variants of the circadian rhythm genes are associated 
with the risk factors for the development of cardiovascular diseases such as blood 
pressure, glucose concentration [23, 37]. An overview of the essential circadian 
rhythm genes with their roles is shown in Table 1 [38, 39].
Figure 1. 
The molecular mechanism of circadian rhythm in humans. ARNTL and CLOCK activate transcription 
of CRY and PER, nuclear receptors (REV-ERBα and RORα) and other clock-controlled genes. CRY and 
PER heterodimerize and phosphorylate by casein kinases and translate into the nucleus where they prevent 
binding of the ARNTL-CLOCK to the regulatory regions of target genes. In the second feedback loop, REV-
ERBα prevents the transcription of ARNTL because it binds to the RRE element, while overnight the same 
regulatory elements bind RORα and activate transcription of ARNTL. Also, ARNT-CLOCK heterodimers 
activate transcription of the REV-ERBα and RORα proteins. ARNTL—aryl hydrocarbon receptor nuclear 
translocator-like, CLOCK—circadian locomotor output cycles kaput, CRY—cryptochrome, PER—period, 
P—phosphate, RORα—retinoic-related orphan receptor alpha, RRE element—REV-ERB/ROR response 
element, Ub—ubiquitin.
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Numerous studies on animal models, as well as human populations, have 
confirmed the association of the circadian clock gene with metabolic syndrome and 
cardiovascular diseases [15, 40, 41].
4. Cardiovascular diseases
The WHO data for 2017 show that cardiovascular diseases were the cause of 
19.9 million deaths worldwide, and about 80% of deaths from cardiovascular 
diseases were due to myocardial infarction and stroke [42]. It is estimated that by 
2030, 23.6 million people will die annually due to cardiovascular diseases [43].
Cardiovascular diseases are the primary cause of death in developed countries 
of the world, and in less developed parts of the world, this mortality is rising and 
overtaking mortality rates for infectious diseases [44].
There are variable and constant risk factors for cardiovascular disease. The 
variable risk factors are those that can be affected by therapy and lifestyle change, 
such as smoking, hyperlipoproteinemia, hypertension, and to some extent diabetes 
and homocysteinemia. The constant risk factors cannot be affected, namely age, 
genetic predisposition, gender, and menopause. The general risk factors which can 
be altered most are smoking, hypertension and hyperlipidemia, and obesity and 
diabetes whose prevalence has risen in the last few decades. However, some recent 
risk factors (fibrinogen, lipoprotein (a), homocysteine) should not be ignored. All 
of these contribute to total cardiovascular risk [45].
Cardiometabolic risk factors are determined by a cluster of metabolic and 
cardiovascular changes. Diabetes and obesity are also associated with reduced 
quality of life and increased economic burden on the person and society [46, 47]. 
Cardiovascular diseases and type 2 diabetes share common pathophysiological 
Gene Function
ARNTL (Aryl hydrocarbon 
Receptor Nuclear 
Translocator-Like)
Rhythmically expressed. Physically associates with CLOCK. Promotes 
transcription of PER and CRY. It is involved in the risk for hypertension, 
adipogenesis, and glucose metabolism.
CK1ε (Casein kinase 1 ε) Physically associates with and phosphorylates PER. Affects PER stability 
and nuclear localization.
CLOCK (Circadian Locomotor 
Output Cycles Kaput)
Constitutively expressed. Physically associates with ARNTL. Promotes 
transcription of PER and CRY. It is involved in the platelet rhythmic 
activity, response of cardiomyocytes to fatty acids, lipid, and glucose 
metabolism.
CRY1 (Cryptochrome 1)
CRY2 (Cryptochrome 2)
Physically associates with and stabilizes PER. Negative regulator of Per 
and Cry transcription.
PER1 (Period 1)
PER2 (Period 2)
PER3 (Period 3)
Physically associates with CRY. Positive regulator of ARNTL. They are 
involved in the aortic endothelial function.
REV-ERBα (nuclear receptor 
subfamily 1 group D member 1)
Associates with regulatory elements and negative regulator of the 
ARNTL and CLOCK transcription. It is involved in triglyceride and lipid 
metabolism, and circadian activity of PAI-1.
RORα (Retinoic-related orphan 
receptor alpha)
Associates with regulatory elements and positive regulator of the 
ARNTL. It is involved in lipid metabolism.
TIM (Timeless) Circadian function not known. Physically associates with CRY. Negative 
regulator of PER and CRY transcription in vitro.
Table 1. 
The essential circadian rhythm genes in mammals.
Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease
6
mechanisms of insulin resistance and risk factors for cardiovascular diseases, such 
as metabolic syndrome. Excessive weight plays a significant role because fatty tissue 
becomes an active endocrine organ that secretes low-level inflammation mediators, 
and these stimulate the development of metabolic syndrome and vascular diseases 
[32, 48, 49].
5. Myocardial infarction
Myocardial infarction is the leading cause of mortality in developed countries 
and developing countries. It can be caused and triggered by different pathophysio-
logical processes. Myocardial infarction is an inflammatory disease due to the death 
of myocardial cells because of complete coronary circulation interruption, which is 
in most cases a consequence of thrombotic occlusion of the coronary artery at the 
site of the activated atherosclerotic plaque. An electrocardiogram (ECG) of the ST 
elevation is only an indirect indicator of the fact that ischemia affects all three layers 
of cardiac muscle (endocardium, myocardium, and epicardium) [50].
ST-elevation myocardial infarction (STEMI) is the most severe form of acute 
coronary syndrome. Myocardial infarction is accompanied by increased cellular 
oxidative stress in the pericardial cavity [51]. The primary cause of infarction is 
platelet aggregation in the coronary artery. The platelet activity is the highest in 
the morning. Also, in the morning hours, mental and physical activity increase due 
to cortisol and catecholamine elevation, which increases cardiac output [45]. The 
biochemical markers of myocardial damage are cardiac troponin T or troponin I in 
serum. These biochemical markers are more reliable than those previously used, 
such as measurement of creatine kinase (CK). The initial increase in troponin in 
peripheral blood in patients with infarction occurs over 3–4 hours with a permanent 
increase for up to 2 weeks after infarction. In order to confirm or exclude myo-
cardial damage, troponin T serum levels are repeated in the first 6–12 hours after 
severe chest pain [52].
The classification of myocardial infarction in five types was introduced in 2007 
and established the clinical criteria for its exact differentiation [50]. Type 1 is related 
to a coronary plaque rupture, fissuring, or dissection with resulting intraluminal 
thrombosis. Type 2 myocardial infarction is secondary to myocardial ischemia 
resulting from increased oxygen demand or decreased supply. Type 3 myocardial 
infarction is linked to unexpected cardiac death when cardiac biomarkers are 
unavailable. Types 4 and 5 myocardial infarction are procedure related [53].
In the study of Saaby et al., [54] it was shown that the most significant number 
of patients with myocardial infarction come under Type 1 (72%). In patients with 
Type 1 myocardial infarction, changes in the ECG are seen either as the elevation or 
depression of the ST segment; the troponin T level also increases in the blood and 
serves as a diagnostic marker. The troponin T level in the blood is higher in patients 
with Type 1 myocardial infarction than Type 2 [55].
For manifestation of infarction, apart from lifestyle, a genetic background of 
myocardial infarction is also essential. A positive family history of myocardial infarc-
tion is a major cardiovascular risk factor [56]. Coronary artery disease and myocar-
dial infarction have a genetic background in 50–60% of cases. Many genes are found 
in the genetic background of myocardial infarction. Whole genome association 
studies have revealed many variants of genes associated with increased risk for myo-
cardial infarction [56]. So far the most frequently explored genes with increased risk 
for myocardial infarction are involved in the metabolic pathways of lipid metabolism 
and development of type 2 diabetes. The relationship between the circadian rhythm 
genes and the onset of myocardial infarction will be discussed below.
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6. Myocardial infarction and circadian rhythm
Many cardiovascular events and diseases have a circadian pattern of appearance. 
The normal circadian blood pressure shows the two highest values during the day, 
around 9 am and 7 pm, while there is a slight decrease around 3 pm. It is considered 
that circadian variations in the tone of coronary vessels and endothelial function 
play an essential role in the onset of myocardial infarction. As myocardial infarction 
is significant medical stress, it causes increased cortisol levels in plasma [3]. In the 
acute phase of myocardial infarction, the phase of the circadian clock in the isch-
emic part of the heart differs from the non-ischemic part of the heart. The arrhyth-
mia may occur because of the difference in the phase of the rhythm, or different 
expressions of the circadian clock genes. The loss of synchronization of the circa-
dian rhythm between organs or tissues occurs more often than we would expect [4]. 
Circadian regulation of physiological processes is regulated locally. Peripheral tissue 
clocks control tissue-specific expression [27].
Homeostatic changes, gene expression changes, and external triggers can cause a 
stressful environment and cause damage to the atherosclerotic plaque in the coro-
nary arteries in the morning, when prothrombin is increased [57]. Many intrinsic 
vasoactive and cardioactive substances, such as angiotensin II, melatonin, plasmino-
gen activator inhibitor 1 (PAI-1), glucocorticoids, epinephrine, norepinephrine, and 
nitrogen oxide, show a specific circadian pattern. The fibrinolytic system, which 
regulates PAI-1, shows a circadian pattern of occurrence in both healthy patients and 
those with ischemic heart disease. The concentration and activity of PAI-1 depend 
on the circadian rhythm and are the highest in the morning [28]. CLIF (Cycle-Like 
Factor) expression in endothelial cells creates heterodimers with CLOCK protein, 
and binds to the E-box of the PAI-1 gene promoter and promotes its expression, 
while PER2 and CRY1 inhibit expression of PAI-1 by blocking heterodimer CLOCK-
CLIF. CLIF controls the circadian rhythm of PAI-1 in endothelial cells, which might 
explain the higher incidence of myocardial infarction in the morning [26, 58]. As a 
result of this, the fibrinolytic system in patients with MI might be a potential goal 
for chronotherapy, to treat acute cardiovascular events. The circadian clock regu-
lates the endothelial response to vascular injury. The main factor that can be affected 
by potential chronotherapy is PAI-1 because it is a crucial fibrinolysis inhibitor [59]. 
Chronotherapy includes the accurate timing of drug taking and can improve the 
therapeutic efficacy of the drug, while limiting its toxicity [41]. That is why many 
studies support chronotherapy for cardiovascular disease by limiting pathogenesis 
and improving treatment after the occurrence of acute cardiovascular events [59].
It is known that melatonin levels decrease during the night in coronary heart 
disease and infarction. Melatonin is an antioxidant that can inhibit the action of 
reactive oxygen radicals during heart ischemia. It also plays a vital role in regulating 
blood pressure, depending on the circadian rhythm. Animal studies have shown 
that animals with the pineal gland removed develop hypertension. Clinical exami-
nations have shown that in patients with hypertension melatonin drugs taken daily 
before bedtime reduced blood pressure [3].
The appearance of myocardial infarction has two peaks during the day. The 
highest incidence of myocardial infarction is during the morning, and the second 
peak occurs late at night [60]. The beta blockers prevent increased sympathetic 
activity, catecholamine concentration, heart rate, blood pressure and lack of oxygen 
in the heart, and these are the physiological reasons for the existence of two peaks 
of myocardial infarction [57, 61].
Ischemia occurs in the morning due to increased oxygen demand, whereas in 
the evening it is due to decreased coronary blood flow. The appearance of myocar-
dial infarction depends on ethnic origin, and the British differ from Asians in the 
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frequency of the infarction [3]. In the Mediterranean, the highest incidence of myo-
cardial infarction is between midday and midnight, while in the UK the highest inci-
dence is between midnight and midday [62]. Numerous factors might affect the later 
occurrence of infarction in the Mediterranean, such as the number of sunlight hours, 
inequality in the prevalence of risk factors for cardiovascular disease, and the habit of 
afternoon rest or ‘siesta’ [63]. It has also been noted that the incidence of myocardial 
infarction is higher in the winter [3]. The specific circadian pattern of infarction 
symptoms has been observed, and the correlation of the circadian rhythm gene with 
the infarction investigated. The role of the molecular circadian clock in myocardial 
activity was initially investigated on animal models. It has been observed that the clock 
gene mutations of the circadian rhythm affect the heart rate, myocardial contractility, 
energy metabolism, which altogether leads to ischemia [64, 65]. In contrast, variants 
of the Per2 gene in mice reduce the severity of the injury after myocardial infarction 
because it does not only reduce inflammatory response, but also reduces apoptosis, 
induces cardiovascular hypertrophy, and thus preserves cardiac function [65].
Different variations of circadian rhythm genes are associated with many risk 
factors for cardiovascular disease. Thus, CLOCK gene variations are associated with 
metabolic syndrome in humans, type 2 diabetes, and some with stroke [64, 66–68], 
while CRY2 and PER2 gene variations are associated with myocardial infarction 
[69]. Expression of CRY1 and PER2 genes in fatty tissue is associated with meta-
bolic syndrome in humans [64, 70]. Metabolic syndrome is a significant risk factor 
for cardiovascular disease and contributes to the common pathophysiological 
processes leading to the development of diabetes and cardiovascular diseases [48]. 
Atherosclerotic changes in blood vessels in patients with diabetes are more severe 
than those with normal glucose concentration [71]. It has been shown that the risk 
of cardiovascular disease in diabetic patients is two to three times higher than in 
healthy subjects [72]. Patients with diabetes usually have a higher heart rate in sleep 
and lower heart rate variability over the day than people without diabetes, which 
causes unnecessary oxygen consumption in the myocardium, with reduced nutri-
tional blood supply. Biological and epidemiological studies suggest a direct link 
between lifestyle and metabolic disorders [12], although the genetic and biochemi-
cal linkage of human circadian rhythm with metabolic disorders has not been fully 
explored. Accordingly, the importance of the circadian rhythm in maintaining 
‘energy’ homeostasis and metabolism is evident.
6.1 Cardiomyocyte circadian clock
A peripheral clock is also found in cardiomyocytes, and the internal molecular 
mechanism of cardiomyocytes, such as the circadian clock, might contribute to 
cardiovascular disease [73]. Similar to SCN, cardiomyocytes have a circadian 
expression of clock genes in response to serum shock or norepinephrine. Several 
genes are associated with intracellular metabolism or physiological activity that has 
a circadian expression in cardiomyocytes [74]. After development, cardiomyocytes 
do not replicate, although they possess a meager and permanent rate of renewal. 
Cardiomyocytes renew cellular structure with their new proteins and membrane 
lipids every few weeks [75]. The ischemic precondition is an adaptation of cardio-
myocytes to hypoxia, and once the heart has suffered an ischemic insult, cardio-
myocytes become more resistant to MI because of PER2 and hypoxia inducible 
factor (HIF)-1a [74]. Circadian genes regulate a group of genes encoding for cardiac 
metabolic enzymes, and it is considered that a significant role of circadian genes in 
the heart is to synchronize cardiomyocyte metabolic activity with the availability 
of nutrients in the blood (i.e., feeding time) [29]. It is known that PER2 plays an 
essential role in carbohydrate metabolism during myocardial ischemia [76].
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The cardiomyocyte circadian clock affects the daily variations in the heart. 
Studies show that the cardiomyocyte circadian clock affects myocardial contrac-
tions, the metabolism and gene expression. This clock is vital since impairment 
of the cardiomyocyte circadian clock might significantly alter cardiac function, 
cardiovascular disease pathogenesis, and treatment strategies for cardiovascular 
diseases (e.g., chronopharmacology) [77]. Desynchronization between different 
cell types (e.g., cardiomyocytes, vascular smooth muscle cells, endothelial cells) 
could occur within the organs (e.g. the heart) during certain physiological or 
pathological conditions [78]. The cardiomyocyte circadian clock allows the heart 
to predict circadian rhythm by extracellular stimuli, allowing rapid and temporally 
response [77]. The cardiomyocyte circadian clock has a crucial role in mediating 
the daily rhythm in myocardial metabolism and affects the cardiovascular function 
[79]. The cardiomyocyte circadian clock changes during illness, and this molecular 
mechanism might affect the etiology of cardiovascular disease [78].
7. Conclusions
Circadian rhythm adjusts the physiological functions of an individual on a daily 
basis. Daily variations of physiological parameters in the cardiovascular system 
maintain cardiovascular function according to the needs of different activities 
during the day. This information suggests that we need to know not only how, but 
also when to treat heart disease, and also to treat pathological changes not only 
symptomatically but to treat non-symptomatic but potentially harmful changes in 
the circadian rhythm.
Understanding the pathophysiological processes involved in the onset of myo-
cardial infarction requires additional studies to assess the crucial elements of the 
circadian rhythm. In today’s personalized medicine, knowledge of the circadian 
rhythm (i.e., the genetic background) of an individual can be significant for treat-
ment and should be included as an essential part of the diagnostic process.
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